A review of the reliability and validity of the Edmonton Symptom Assessment System

L A Richardson, G W Jones, L A Richardson, G W Jones

Abstract

Background: Systematic symptom reporting by patients and the use of questionnaires such as the Edmonton Symptom Assessment System (ESAS) have potential to improve clinical encounters and patient satisfaction. We review findings from published studies of the ESAS to guide use of the system and to focus research.

Methods: A systematic search for articles from 1991 through 2007 found thirty-nine peer-reviewed papers from 25 different institutions, thirty-three of which focused on patients with cancer. Observations, data, and statistics were collated according to relevance, reliability, validity, and responsiveness.

Results: Findings apply predominantly to symptomatic palliative patients with advanced cancer who were no longer receiving active oncologic therapies. Uncertainty about summarizing findings arises from frequent modification of the ESAS (altered items, scales, and time periods). Overall, reliability is established for daily administration. Scores are skewed, with a floor effect, but the relative order of symptoms by mean scores is similar across studies. Emotional symptoms are poorly captured by the depression and anxiety items. An equally weighted summation of scores may estimate a construct of "physical symptom distress," which in turn is related to performance status, palliative goals, quality of life, and well-being.

Conclusions: The ESAS is reliable, but it has restricted validity, and its use requires a sound clinical process to help interpret scores and to give them an appropriate level of attention. Research priorities are to further develop the ESAS for assessing a greater number of important physical symptoms (and to target "physical symptom distress"), and to develop a similar instrument for emotional symptoms.

Keywords: Symptom screening; esas; reliability; review; validity.

References

    1. Davidson SE, Trotti A, Ataman OU, et al. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys. 2007;69:1218–21.
    1. Cancer Care Ontario (CCO) and Action Cancer Ontario. Patient satisfaction with outpatient cancer care, Toronto Central lhin [Web page] Toronto: CCO; 2007. [Available at: ; cited August 24, 2007]
    1. Hearn J, Higginson IJ. Outcome measures in palliative care for advanced cancer patients: a review. J Public Health Med. 1997;19:193–9.
    1. Roth AJ, Kornblith AB, Batel–Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82:1904–8.
    1. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A:1326–36.
    1. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (esas): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6–9.
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer qlq-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
    1. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–9.
    1. Strömgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P. Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer. 2002;38:788–94.
    1. Kirkova J, Davis MP, Walsh D, et al. Cancer symptom assessment instruments: a systematic review. J Clin Oncol. 2006;24:1459–73. [Erratum in: J Clin Oncol 2006;24:2973]
    1. Dudgeon DJ, Harlos M, Clinch JJ. The Edmonton Symptom Assessment Scale (esas) as an audit tool. J Palliat Care. 1999;15:14–19.
    1. Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 2001;29:277–82.
    1. Brechtl JR, Murshed S, Homel P, Bookbinder M. Monitoring symptoms in patients with advanced illness in long-term care: a pilot study. J Pain Symptom Manage. 2006;32:168–74.
    1. Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006;9:296–303.
    1. Heedman PA, Strang P. Symptom assessment in advanced palliative home care for cancer patients using the esas: clinical aspects. Anticancer Res. 2001;21:4077–82.
    1. Salminen E, Clemens KE, Syrjänen K, Salmenoja H. Needs of developing the skills of palliative care at the oncology ward: an audit of symptoms among 203 consecutive cancer patients in Finland. Support Care Cancer. 2008;16:3–8.
    1. Moro C, Brunelli C, Miccinesi G, et al. Edmonton Symptom Assessment Scale: Italian validation in two palliative care settings. Support Care Cancer. 2006;14:30–7.
    1. Walke LM, Byers AL, Gallo WT, Endrass J, Fried TR. The association of symptoms with health outcomes in chronically ill adults. J Pain Symptom Manage. 2007;33:58–66.
    1. Cancer Care Ontario (CCO) and Action Cancer Ontario. Provincial Palliative Care Integration Project: Resource Manual. Edmonton Symptom Assessment System (esas) Toronto: CCO; 2005. [Available online at: ; cited August 15, 2007]
    1. Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson J, Maguire TO. A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med. 1999;13:311–23.
    1. Nekolaichuk CL, Maguire TO, Suarez–Almazor M, Rogers WT, Bruera E. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol. 1999;17:3621–30.
    1. Jenkins CA, Schulz M, Hanson J, Bruera E. Demographic, symptom, and medication profiles of cancer patients seen by a palliative care consult team in a tertiary referral hospital. J Pain Symptom Manage. 2000;19:174–84.
    1. Bruera E, Michaud M, Vigano A, Neumann CM, Watanabe S, Hanson J. Multidisciplinary symptom control clinic in a cancer center: a retrospective study. Support Care Cancer. 2001;9:162–8.
    1. Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int. 2006;69:1621–5.
    1. Chow E, Wong R, Connolly R, et al. Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program. Feasibility of telephone follow-up. J Pain Symptom Manage. 2001;22:649–56.
    1. Chow E, Davis L, Holden L, Tsao M, Danjoux C. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage. 2005;30:18–23.
    1. Bradley N, Davis L, Chow E. Symptom distress in patients attending an outpatient palliative radiotherapy clinic. J Pain Symptom Manage. 2005;30:123–31.
    1. Chow E, Fan G, Hadi S, Filipczak L. Symptom clusters in cancer patients with bone metastases. Support Care Cancer. 2007;15:1035–43.
    1. Easson AM, Bezjak A, Ross S, Wright JG. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites. Ann Surg Oncol. 2007;14:2348–57.
    1. Riechelmann RP, Krzyzanowska MK, O’Carroll A, Zimmermann C. Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer. 2007;15:1407–12.
    1. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88:2164–71.
    1. Garyali A, Palmer JL, Yennurajalingam S, Zhang T, Pace EA, Bruera E. Errors in symptom intensity self-assessment by patients receiving outpatient palliative care. J Palliat Med. 2006;9:1059–65.
    1. Nainis N, Paice JA, Ratner J, Wirth JH, Lai J, Shott S. Relieving symptoms in cancer: innovative use of art therapy. J Pain Symptom Manage. 2006;31:162–9.
    1. Walke LM, Gallo WT, Tinetti ME, Fried TR. The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med. 2004;164:2321–4.
    1. Åstradsson E, Granath L, Heedman PA, Starkhammar H. Cancer patients hospitalised for palliative reasons. Symptoms and needs presented at a university hospital. Support Care Cancer. 2001;9:97–102.
    1. Heedman PA, Strang P. Pain and pain alleviation in hospital-based home care: demographic, biological and treatment factors. Support Care Cancer. 2003;11:35–40.
    1. Lindemalm C, Strang P, Lekander M. Support group for cancer patients. Does it improve their physical and psychological well-being? A pilot study. Support Care Cancer. 2005;13:652–7.
    1. Strömgren AS, Groenvold M, Pedersen L, Olsen AK, Spile M, Sjøgren P. Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage. 2001;21:189–96.
    1. Strömgren AS, Goldschmidt D, Groenvold M, et al. Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer. 2002;94:512–20.
    1. Labori KJ, Hjermstad MJ, Wester T, Buanes T, Loge JH. Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study. Support Care Cancer. 2006;14:1126–33.
    1. Teunissen SC, de Graeff A, Voest EE, de Haes JC. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med. 2007;21:341–6.
    1. Rees E, Hardy J, Ling J, Broadley K, A’Hern R. The use of the Edmonton Symptom Assessment Scale (esas) within a palliative care unit in the U.K. Palliat Med. 1998;12:75–82.
    1. Pautex S, Berger A, Chatelain C, Herrmann F, Zulian GB. Symptom assessment in elderly cancer patients receiving palliative care. Crit Rev Oncol Hematol. 2003;47:281–6.
    1. Tassinari D, Montanari L, Maltoni M, et al. The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer. 2007;16:359–70.
    1. Modonesi C, Scarpi E, Maltoni M, et al. Impact of palliative care unit admission on symptom control evaluated by the Edmonton Symptom Assessment System. J Pain Symptom Manage. 2005;30:367–73.
    1. Porzio G, Ricevuto E, Aielli F, et al. The Supportive Care Task Force at the University of L’Aquila: 2-years experience. Support Care Cancer. 2005;13:351–5.
    1. Philip J, Smith WB, Craft P, Lickiss N. Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer. 1998;6:539–41.
    1. Tierney RM, Horton SM, Hannan TJ, Tierney WM. Relationships between symptom relief, quality of life, and satisfaction with hospice care. Palliat Med. 1998;12:333–44.
    1. Lam PT, Leung MW, Tse CY. Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J. 2007;13:453–9.
    1. Paul–Dauphin A, Guillemin F, Virion JM, Briançon S. Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol. 1999;150:1117–27.
    1. Bruera E, MacDonald S. Audit methods: the Edmonton Symptom Assessment System. In: Higginson I, editor. Clinical Audit in Palliative Care. Oxford: Radcliffe Medical Press; 1993. pp. 61–77.
    1. Regional Palliative Care Program. Guidelines for Using the Edmonton Symptom Assessment System (esas) Edmonton, AB: Regional Palliative Care Program; 2001. [Available online at: ; cited August 15, 2007]
    1. Higginson IJ, Sen–Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3:287–300.
    1. Homsi J, Walsh D, Rivera N, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. 2006;14:444–53.
    1. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284:2476–82.
    1. Yennurajalingam S, Zhang T, Bruera E. The impact of the palliative care mobile team on symptom assessment and medication profiles in patients admitted to a comprehensive cancer center. Support Care Cancer. 2007;15:471–5.
    1. McCorkle R, Young K. Development of a Symptom Distress Scale. Cancer Nurs. 1978;1:373–8.
    1. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990;62:1034–8.
    1. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197–210.
    1. National Comprehensive Cancer Network (nccn) nccn practice guidelines for the management of psychosocial distress. Oncology (Williston Park) 1999;13:113–47.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70.
    1. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (kdqol) instrument. Qual Life Res. 1994;3:329–38.
    1. Steinberg T, Dobson S, Kasymjanova G, et al. Prevalence of emotional distress in newly diagnosed lung cancer patients [abstract] Support Care Cancer. 2007;15:734–5.
    1. Di Dio P, Chasen M, Eades M, et al. Use of the distress thermometer in patients enrolled in a cancer nutrition and rehabilitation program [abstract] Support Care Cancer. 2007;15:777.
    1. Higginson I. Audit methods: a community schedule. In: Higginson I, editor. Clinical Audit in Palliative Care. Oxford, U.K.: Radcliffe Medical Press; 1993. pp. 34–47.
    1. Higginson I. Audit methods: validation and in-patient use. In: Higginson I, editor. Clinical Audit in Palliative Care. Oxford, U.K.: Radcliffe Medical Press; 1993. pp. 48–54.
    1. Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med. 1995;9:207–19.
    1. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C on behalf of the Clinical Significance Consensus Meeting Group. Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc. 2002;77:479–87.
    1. Nezu AM, Nezu CM. Psychological distress, depression, and anxiety. In: Feurestein M, editor. Handbook of Cancer Survivorship. New York: Springer; 2007. pp. 323–37.
    1. Krohne HW. Individual differences in emotional reactions and coping. In: Davison RJ, Scherer KR, Goldsmith HH, editors. Handbook of Affective Sciences. New York: Oxford University Press; 2003. pp. 698–725.
    1. College of Physicians and Surgeons of Ontario. Changing scope of practice. MD Dialogue. 2008;4:7–10.
    1. Ceresia P. Information Sheet 077E. Ottawa: Canadian Medical Protective Association; 2007. Medico-Legal Issues Arising from New Health-Care Technologies.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel